Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study

November 5, 2021 updated by: Ju Seok Ryu, Seoul National University Hospital
The purpose of this study is to: 1) secure basic data of patients with cerebral palsy, 2) seek ways to simplify the data for clinical application, 3) progress of hip dislocation, presence or absence of hip surgery, and The purpose of this study is to compare differences in body development according to severity and nutritional methods.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

196

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bundang-gu
      • Seongnam-si, Bundang-gu, Korea, Republic of, 13354
        • Seoul National University Bundang Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 13 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

It is difficult to find the basis for calculation because there are no papers that measure the body size of children with cerebral palsy and papers that compare with normal children. In particular, children with cerebral palsy are rare diseases, and it is difficult to recruit a large number of subjects.

Description

Inclusion Criteria:

  • aged 1 to 13
  • Experiment group: Children with cerebral palsy, Control group: Normal children
  • Patients who agreed to participate in the study

Exclusion Criteria:

  • do not agree with the study
  • Those who find it difficult to participate under the judgment of the research director

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Children with stiff cerebral palsy
Children with stiff cerebral palsy, aged 1 to 13 years
Normal children
Normal children, aged 1 to 13 years

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anthropometric data (body length)
Time Frame: through study completion, an average of 1 year
Measure the body length using a tape measure.(cm)
through study completion, an average of 1 year
Anthropometric data (BMI)
Time Frame: through study completion, an average of 1 year
weight and height will be combined to report BMI in kg/m^2
through study completion, an average of 1 year
Anthropometric data (body circumference )
Time Frame: through study completion, an average of 1 year
Measure the body circumference using a tape measure.(cm)
through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Progression of hip dislocation
Time Frame: Use simple x-ray within 1 year prior to participation
It is measured by migration index, which measures the proportion of femoral heads not covered by acetabulum
Use simple x-ray within 1 year prior to participation
Progression of scoliosis
Time Frame: Use simple x-ray within 1 year prior to participation
The degree of scoliosis is measured by Cobbs angle
Use simple x-ray within 1 year prior to participation
Have hip dislocation surgery
Time Frame: through study completion, an average of 1 year
Confirmation of hip dislocation surgery
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 27, 2019

Primary Completion (Actual)

September 6, 2021

Study Completion (Actual)

September 6, 2021

Study Registration Dates

First Submitted

July 20, 2020

First Submitted That Met QC Criteria

July 23, 2020

First Posted (Actual)

July 28, 2020

Study Record Updates

Last Update Posted (Actual)

November 8, 2021

Last Update Submitted That Met QC Criteria

November 5, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • B-1909/562-302

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

3
Subscribe